The outgrowth of neuronal processes involves a great increase in the surface area of the cell. The supply of membrane material necessarily must be coordinated with the demands for neurite growth. The selective growth of only one or two neurites at any given time during the development of polarity raises the possibility that the production of materials by the soma is limiting for growth (Dotti and Banker, 1987; Dotti et al., 1988; Goslin and Banker, 1990) . To examine the role of the availability of membrane components during the development of polarity and axonal elongation, we treated neurons with brefeldin A, an antibiotic that disrupts the trafficking of vesicles from the Golgi complex to the plasma membrane. Treatment with brefeldin A
Axonal growth involves a great increase in volume and surface area. Hence, growth cone advance and the transport of cytoskeletal and membrane constituents must be linked. The selective transport of these constituents may underlie the selective outgrowth of neurites observed during synapse formation or the development of neuronal polarity (Dotti et al., 1988; O'Rourke and Fraser, 1990) . Indeed, differential transport of vesicular elements has been observed directly in different branches of the neurites of cultured Apl ysia neurons (Goldberg and Schacher, 1987) .
Few experiments have examined the link between axonal growth and the supply of materials produced in the cell body. One such experiment used optical tweezers to trap materials transported along the neurites of chick sensory neurons (Martenson et al., 1993) . This led, after a delay of minutes, to collapse of the growth cone and cessation of elongation. The latency between blockade of vesicle transport and inhibition of growth suggested that outgrowth depends, on a moment-to-moment basis, on the delivery of some element moving by rapid axonal transport.
Disruption of axonal transport may simultaneously interrupt the supply of membrane constituents, cytoskeletal elements, and regulatory components governing their assembly. To investigate more specifically the importance of membrane elements in neurite growth, we have examined the effects of brefeldin A (BFA) on the development of cultured hippocampal neurons. BFA acts by inhibiting a Golgi-associated guanine nucleotide exchange protein acting on ADP-ribosylation factor (ARF) (Donaldson et al., 1992; Helms and Rothman, 1992) . Because ARF1 plays a central role in controlling vesicular traffic from the endoplasmic reticulum (ER) to the Golgi complex and between successive Golgi compartments, BFA treatment results in the redistribution of coat proteins from Golgi membranes to cytosol, the inhibition of vesicular traffic from the Golgi complex, and the collapse of the Golgi complex into the ER (Dascher and Balch, 1994; Elazar et al., 1994; Zhang et al., 1994) . BFA also affects the recycling of endocytosed proteins also via ARF family members, but unlike the biosynthetic pathway, membrane recycling continues, although at a slower rate (Damke et al., 1991; Lippincott-Schwartz et al., 1991; Barroso and Sztul, 1994; Schonhorn and WesslingResnick, 1994; Stoorvogel et al., 1996) . In cultured hippocampal neurons, the cell surface expression of proteins via defective herpesvirus vectors and the appearance of Golgi-derived vesicles labeled with fluorescent lipids are blocked by BFA treatment (Craig et al., 1995) .
In this report we examine the effects of BFA on neurite outgrowth and the development of polarity. We confirm that BFA rapidly and reversibly disrupts the Golgi complex and prevents the cell surface expression of exogenous membrane proteins in cultured hippocampal neurons. We then show that neurons that have not yet formed axons fail to do so in the presence of BFA. In neurons that have formed axons at the time of exposure to BFA, axonal elongation ceased within 30 min. Inhibitors of protein synthesis also block the formation and elongation of axons, but their effects on neurite growth are apparent only after several hours.
MATERIALS AND METHODS
Materials. Brefeldin A (Epicentre Technologies, Madison, W I) was stored at Ϫ20°C as a stock solution of 5 mg /ml in ethanol. BFA was added directly to the culture medium at a final concentration of 3.57 M (1 g /ml) in all experiments, unless otherwise noted. C ycloheximide (71 M; 7.1 mM aqueous stock solution), emetine (40 M; 1.6 mM aqueous stock solution), or puromycin (50 M; 2 mM aqueous stock solution) was added to the medium to inhibit protein synthesis. Actinomycin D (8 M; 1.6 mM aqueous stock solution) was added to the medium to inhibit the synthesis of RNA. The cultures were rinsed twice in M EM, and then glial-conditioned medium was added to the dish to examine the effects of drug removal.
Cell culture. Methods for preparing hippocampal cell cultures have been described previously (Goslin and Banker, 1992) . In brief, cell suspensions were prepared by trypsin treatment of hippocampi (dissected from the brains of 18 d rat fetuses) and trituration using a fire-polished Pasteur pipette. Dissociated cells were plated on poly-L-lysine-treated glass coverslips in M EM. After allowing 3-4 hr for cells to adhere, we transferred the coverslips to a new dish, such that a space of ϳ1 mm separated the coverslip from a monolayer of glia. The medium in this dish was glial-conditioned M EM containing the N2 supplements of Bottenstein and Sato (1979) , together with sodium pyruvate and ovalbumin (0.1%).
For experiments involving video microscopy of individual neurons, coverslips were placed in sealed chambers designed for time-lapse microscopy or in special culture dishes prepared as described by Goslin and Banker (1990) .
V isualization of the Golg i apparatus. One-day-old neurons were fixed in cold MeOH, and the Golgi complex was visualized with an antibody to the Golgi protein mannosidase II (generous gift of Dr. Kelly Moremen, University of Georgia, Athens, GA, and Dr. Marilyn Farquahr, University of C alifornia, San Diego, San Diego, CA). The rabbit polyclonal antibody was incubated at a dilution of 1:1000, followed by incubations in biotinylated goat anti-rabbit IgG (1:800; Vector Laboratories, Burlingame, CA) and then in FI TC -streptavidin (1:800; Vector).
The Golgi complex was also visualized by staining living cells with N- (4,4-difluoro-5,7-dimethyl-bora-3a,4a-diaza-s-indacene-3-pentanoyl) sphingosine (DM B-ceramide). A complex of DM B-ceramide with defatted BSA was prepared by adding 100 l of a 500 M stock of DM Bceramide to 10 ml of M EM containing defatted BSA (0.34 mg /ml), as described by Lipsky and Pagano (1985) . This solution was then dialyzed against 500 ml of M EM overnight at 4°C, resulting in a final concentration of ϳ5 M for both DM B-ceramide and the defatted BSA. Cultures were incubated with the 5 M DM B-ceramide and defatted BSA complex in M EM for 15 min at 37°C. After incubation, the M EM was replaced with glial-conditioned medium, and cells were examined by fluorescence microscopy using a planapo 63ϫ objective.
E xpression of e xogenous proteins. To test the actions of BFA on the transport of integral membrane proteins to the cell surface in cultured neurons, we expressed exogenous proteins using replication-defective adenovirus. Adenovirus expressing low density lipoprotein receptor (LDLR) (generous gift of Dr. Robert Gerard, University of Texas, Southwestern Medical C enter, Dallas, TX; Herz and Gerard, 1993) was added to cultures 18 hr after plating, and BFA was added 4 hr later. C ell surface expression from adenovirus vectors is first detectable 8 hr after infection (M. Jareb and G. Banker, unpublished observations). LDLR expression in control and BFA-treated cultures was visualized with the monoclonal antibody C7 (Amersham, Arlington Heights, IL) 12 hr after BFA treatment (16 hr after infection). To examine cell surface staining, we incubated living neurons with primary antibody for 5 min at 37°C and then fixed the neurons in 4% paraformaldehyde and 4% sucrose in PBS. Other cultures were fixed and permeabilized before staining to reveal both intracellular and surface labeling.
Effects of inhibitors on development of polarit y. The effect of inhibitors on the morphological development of cultured hippocampal neurons was examined by treating cultures with a drug during the period when most neurons initially form their axons. Cultures were treated with BFA, cycloheximide (CHX), actinomycin D (AC T D), or vehicle 18 hr after plating and then fixed in 2.5% glutaraldehyde 1-12 hr later. Randomly chosen fields were examined, and the proportion of cells that had developed axons was determined. A cell was considered to have an axon if the length of one process was at least twice as long as any other process and was more than twice the diameter of the cell body (Deitch and Banker, 1993) . C ells with multiple axons were not counted. At least 100 cells from each of two or three coverslips were examined. Repeated-measures ANOVA was used to compare mean changes in the percentage of neurons with axons after drug treatment. When appropriate, post hoc comparisons between control and drug-treated cultures were made using Student's t tests.
Effects of inhibitors on neurite elongation. The effect of inhibitors on neurite elongation was examined by following the growth of individual cells, beginning ϳ24 hr after plating. C ells at stage 3 of development were chosen, and their positions were marked on the coverslip with a diamond-tipped object marker. Observations were made at intervals of 0.5-3 hr, beginning 2 hr before drug addition and continuing for up to 12 hr. Between observations, the cultures were returned to the incubator. During each experiment, 12 randomly chosen stage 3 cells were followed from both drug-treated and vehicle-treated cultures. Process length was measured using Image-1 image analysis software (Universal Imaging Corporation, West Chester, PA). Repeated-measures ANOVA was used to compare mean changes in the relative length of axons or minor processes after drug treatment. When appropriate, post hoc comparisons between control and drug-treated cultures were made using Student's t tests.
RESULTS

Brefeldin A disrupts the Golgi complex in hippocampal neurons and prevents the cell surface expression of membrane proteins
We examined the effects of BFA on the organization of the Golgi complex in cultured hippocampal neurons, visualizing the Golgi complex with a rabbit polyclonal antibody to the Golgi resident protein mannosidase II. In all control neurons (Fig. 1) , the Golgi complex formed a discrete spot, which was usually associated with an indentation in the nucleus that faces the cytoplasm of the soma, as described previously (Dotti and Banker, 1991; Deitch and Banker, 1993) . Treatment with BFA (3.57 M) rapidly and reversibly disrupted the Golgi complex. Within 15 min, in every BFA-treated neuron, the Golgi complex became dispersed throughout the cytoplasm of the cell body (Fig. 1 ). Thirty minutes after BFA was removed, the Golgi complex in most neurons had assumed its normal appearance and localization (Fig. 1) . Similar results were obtained when DM B-ceramide, a fluorescent lipid analog, was used to visualize the Golgi complex in living cells (data not shown) (Pagano et al., 1991) .
We tested the ability of BFA treatment to block protein transport through the Golgi complex in rat hippocampal neurons by expressing an exogenous membrane protein, the LDLR, using an adenovirus vector. BFA was added to cultures 4 hr after infection, and LDLR expression was examined 12 hr later. In control neurons LDLR was expressed on the surface of minor processes, cell bodies, and proximal portions of the axon (Fig. 2) . Live staining of sister cultures treated with BFA and infected with LDLR adenovirus revealed no detectable surface labeling (data not shown). To confirm that BFA-treated cultures were infected, we detected LDLR expression in permeabilized neurons, in which it exhibited a tubular appearance consistent with an intracellular localization (Fig. 2) . This is consistent with previous work that shows that cell surface expression of the T-cell marker CD8 introduced into rat hippocampal neurons via replication-defective herpesviruses is blocked by BFA (Craig et al., 1995) .
Brefeldin A inhibits the development of polarity
During the first 48 hr after plating, the vast majority of hippocampal neurons undergo the transformation from a round, unpolarized cell to a polarized neuron with a single axon. Most cells develop axons and acquire a polarity between 18 and 36 hr after plating. To determine whether exposure to BFA influences the development of polarity, we examined the effects of adding BFA (3.57 M) to hippocampal cultures 18 hr after plating. Figure 3 illustrates representative fields from a control culture 24 hr after plating and from a culture treated with BFA 18 hr after plating and examined 6 hr later. In the untreated culture (Fig. 3A) , approximately half of the neurons have formed a single axon in addition to several minor processes (stage 3 of Dotti et al., 1988) . The other neurons had several minor processes but had not yet developed axons (stage 2 of development). In the culture treated with BFA (Fig. 3B) , most of the neurons had not formed axons.
We quantified the effects of BFA on the development of morphological polarity by fixing cultures at varying times after the addition of BFA and counting the number of neurons that had formed axons (Fig. 4) . In control cultures, the percentage of neurons with axons increased at an approximately linear rate (ϳ3% of cells formed axons each hour), with ϳ50% of the cells having formed axons by 30 hr after plating. In cultures treated with BFA, the normal increase in the percentage of neurons with axons was significantly reduced within 1 hr ( p Ͻ 0.05). Six hours after adding BFA, the percentage of neurons with axons had actually fallen slightly. After removal of BFA, cells resumed forming axons at the rate observed in control cultures. As shown in Figure 4 B, inhibition of the development of polarity by BFA was dose-dependent. Axonal development was significantly inhibited at 0.71 M BFA and was completely blocked at a concentration of 3.57 M. No significant inhibition of axonal development was observed at a concentration of 0.14 M BFA.
Although it is not surprising that a drug that blocks secretion and disrupts pathways through the Golgi complex might interfere with the formation of the axon, we were struck by the rapidity of its action on axonal development. To provide a frame of reference for this result, we compared the time course of action of BFA with that of cycloheximide, an inhibitor of protein synthesis, and actinomycin D, an RNA synthesis inhibitor. Obviously, blockade of protein synthesis generally (either directly or by depletion of mRNAs) or of the Golgi-mediated synthesis of membrane constituents is ultimately likely to block neurite outgrowth and therefore the development of neuronal polarity. Hence, these experiments were intended to compare the time courses of the effects of these drugs on the development of polarity. Figure 5 compares the effects of BFA (3.57 M), cycloheximide (CHX; 71 M), and actinomycin D (ACT D; 8 M). BFA inhibited the development of polarity much more rapidly than either CHX or ACT D. Compared with control cultures, the change in the percentage of BFA-treated neurons with axons was significantly reduced within 1 hr after drug addition ( p Ͻ 0.05). In Figure 2 . The effects of brefeldin A on the cell surface expression of proteins in cultured hippocampal neurons by replication-defective adenovirus. LDLR was expressed in 1-d-old neurons using replication-defective adenovirus. The distribution of LDLR was visualized by immunofluorescence. The fluorescence micrographs illustrate a representative cell from a control culture 16 hr after infection (A, C) and from a culture exposed to BFA (3.57 M) 4 hr after infection and fixed 12 hr later (B, D) . In the control cultures, cell surface labeling was observed on minor processes, the cell body, and the proximal axon. In BFA-treated cultures, labeling was confined primarily to the cell body and exhibited a tubular appearance. When BFA-treated cultures were exposed to antibody before fixation (to prevent intracellular labeling), no staining was observed. Scale bar, 20 m. contrast, the change in the percentage of polarized neurons in cultures treated with CHX (71 M) was significantly reduced in comparison with controls only after 6 hr of treatment ( p Ͻ 0.05). This concentration of CHX inhibits protein synthesis in cultured hippocampal neurons by Ͼ90% (Kleiman et al., 1993) . Similar results were observed with emetine (18 M) and puromycin (46 M), protein synthesis inhibitors with different modes of action than CHX. Inhibition of the development of polarity by ACT D (8 M) followed an even longer time course. These data show that BFA has a much more rapid effect on the development of polarity than does the inhibition of either RNA or protein synthesis.
The effects of BFA on axonal elongation
To determine whether BFA also inhibits the elongation of axons that have formed previously, we followed the growth of individual cells in BFA by video microscopy for up to 12 hr. Figure 6 illustrates a typical example. Before the addition of BFA, the axon of this cell was elongating at 5 m/hr. Within 1 hr of treatment, axonal elongation had ceased completely. After 3 hr, a slight retraction of the axon had occurred, and this became more pronounced over time. Although elongation ceased, the morphology and motility of the axonal growth cone appeared normal for 6 hr or more. By comparison with the axon, minor processes were relatively unaffected. Some retraction was observed at 3 and 6 hr, , the proportion of neurons that developed axons increased at an approximately constant rate. All three drugs inhibited the development of a polarized morphology, but the effects of BFA were much more rapid. After addition of BFA, a reduction in the expected increase in the number of polarized cells was evident by 1 hr ( p Ͻ 0.05, compared with control cultures). A statistically significant reduction in the proportion of neurons that had developed axons was first apparent 6 hr after addition of cycloheximide and 9 hr after addition of actinomycin D. Time points represent means from three experiments. In each experiment at each time point, two or three coverslips were fixed, and the proportion of cells with axons was determined, based on counts of 200 -300 cells.
but by 12 hr these processes had re-extended to their former length despite the continued presence of the drug.
To assess f urther the effects of BFA on growth cone morphology, we followed individual cells by time-lapse recording for up to 12 hr (Fig. 7) . After Ͼ6 hr of BFA treatment, 86% of the neurons still exhibited prominent growth cones. Surprisingly, although BFA-treated neurons showed a marked net retraction of the axon over time, axons still exhibited occasional spurts of growth, and their growth cones remained motile.
The effects of CHX on axonal elongation were quite different (Fig. 8) . In the example shown, the axon continued to elongate at its previous rate for Ͼ3 hr after addition of CHX. Subsequently, elongation stopped, and the axon retracted somewhat, but this was not nearly as pronounced as was observed in BFA-treated neurons. Coincident with inhibition of axonal growth, the axon became noticeably thinner, and its growth cone disappeared. Minor processes of CHX-treated neurons appeared unaffected.
Figure 9 summarizes our observations of the effects of BFA and cycloheximide on the rate of axonal elongation. When BFA was added ϳ24 hr after plating, the average net growth of axons was significantly reduced within 30 min compared with controls. By 1 hr, axonal elongation was completely inhibited. Net retraction of axons became pronounced by 4 hr after addition of BFA, and by 12 hr axons had retracted an average of 50 m. In contrast, the average net growth of CHX-treated axons was significantly inhibited only after 6 hr, and the average retraction of axons was much less pronounced than that seen in BFA-treated cultures. Neither drug systematically affected the growth or retraction of minor processes. Minor processes in control cultures exhibited spurts of elongation and retraction of up to 20 m, but the average net growth of minor processes over the 12 hr examined was Ͻ1 m. Minor processes in drug-treated cultures exhibited similar, dynamic elongation and retraction; neither BFA nor CHX caused a marked retraction of minor processes.
The effects of BFA on neuronal polarity
Previous work has shown that transection of the axon in stage 3 cells can alter the polarity of the neuron (Goslin and Banker, 1990) . If the axon is transected near the cell body, at approximately the same length as the other processes of the cell, a new axon may form from one of the other minor processes of the cell. In contrast, if the axon is transected at some distance from the cell body, so that the axonal stump remains significantly longer than the other processes of the cell, the transected axon regenerates, maintaining the initial polarity of the cell. We were interested in determining whether axonal retraction induced by BFA could similarly alter the polarity of neurons. We followed individual cells during exposure to BFA to determine the degree of axonal retraction; then we removed BFA and examined the subsequent response of the cell for up to 48 hr. Figure 10 illustrates a neuron whose axon retracted back to the length of a minor process after 6 hr of exposure to BFA. When BFA was removed and the cell was examined 12 hr later, it had again formed an axon. The new axon arose not from the original axon but from one of the minor processes. In 4 of 22 cells, the axon retracted so markedly that the length of the axon was within 15 m of the longest minor process. In three of the four cases, the polarity of the cell was altered after removal of BFA. In contrast, in all 18 cases in which the axon retracted, but still remained at least 15 m longer than the longest minor process, the axon retained its identity after removal of BFA. These data suggest that neurons respond to the BFA-induced changes in axonal length in much the same way as do cells whose axons have been transected.
DISCUSSION
The elongation of neurites involves a large expansion in surface area and volume. The supply of membranous and cytoskeletal elements must meet the demands of growth. Furthermore, the neurites of cultured neurons exhibit selective growth, suggesting that the materials required for growth are limited in quantity. We compared the roles that different components synthesized in the cell body play during axonal growth and the development of neuronal polarity. Brefeldin A, which blocks traffic through the Golgi complex, rapidly inhibited the development of polarity and selectively inhibited axonal elongation in polarized neurons. In- Figure 6 . The effects of brefeldin A on neurite elongation. The culture was treated with BFA (3.57 M) ϳ24 hr after plating. This series of phase contrast micrographs illustrates a cell just before BFA treatment ( A) and 1 hr (B), 3 hr (C), 6 hr (D), and 12 hr ( E) after addition of BFA. Axonal elongation, which was evident before the addition of BFA, was completely inhibited within the first hour after treatment. After 3 hr, retraction of the axon was evident, although the axonal growth cone retained its normal appearance for Ͼ6 hr after addition of BFA. By 12 hr, the axon had retracted Ͼ60 m, and the axonal growth cone had lost any lamellipodia or filopodia. The minor processes seemed primarily unaffected by treatment with BFA. Scale bar, 20 m.
hibition of protein or RNA synthesis also inhibited axonal outgrowth and the development of polarity, but over a much longer time course. These data suggest that the continuous availability of Golgi-derived components is required for axonal growth.
Mechanism of action of BFA
The mechanism of action of BFA is critical to the interpretation of the results presented here. BFA acts by inhibiting the GDP-GTP exchange on ARF1, a protein necessary for the vesicular traffic from the ER to the Golgi complex and between successive Golgi stacks. One caveat concerning the actions of BFA is that they may differ somewhat among different cell types (Ktistakis et al., 1995 (Ktistakis et al., , 1996 . Rat hippocampal neurons seem to respond to BFA similarly to most other cell types, including other neurons. We showed that the Golgi complex is disrupted by BFA treatment and membrane proteins expressed via adenovirus or herpesvirus are unable to reach the cell surface (Craig et al., 1995) . In contrast, Cid-Arregui et al. (1995) found that the cell surface expression of membrane proteins introduced into rat hippocampal neurons with the Semliki Forest virus (SFV) was not blocked by BFA. One possible explanation for this discrepancy is that membrane proteins encoded by SFV may use an ARFindependent mechanism to reach the cell surface. Alternatively, because of rapid expression of proteins via SFV vectors, some surface expression may have occurred before BFA treatment.
In addition to blocking traffic from the Golgi complex in most cells, BFA causes tubulation of the endosomal system and perturbs the recycling of endocytosed proteins (Damke et al., 1991; Schonhorn and Wessling-Resnick, 1994; Stoorvogel et al., 1996) . However, unlike the action of BFA on the biosynthetic pathway, membrane traffic through recycling compartments can continue, although at a slower rate (Damke et al., 1991; LippincottSchwartz et al., 1991; Barroso and Sztul, 1994; Schonhorn and Wessling-Resnick, 1994) . Because BFA causes tubulation of endosomes in hippocampal neurons (Mundigl et al., 1993) , protein recycling likely is also slowed by BFA. Because protein recycling still continues, the effects of BFA caused by perturbation of endocytic processes would be much less severe compared with the complete inhibition of traffic from the Golgi complex.
In Madin-Darby canine kidney cells, a polarized epithelial cell line, BFA also disrupts membrane recycling. A number of apical and basolateral proteins are recycled indiscriminately to both domains in the presence of BFA (Hunziker et al., 1991; Prydz et al., 1992; Wan et al., 1992; Matter et al., 1993) . De Hoop et al. (1995) suggested that a similar missorting of endocytosed proteins may occur in hippocampal neurons. Indiscriminate recycling of axonal membrane proteins could play a role in the effects of BFA on axonal elongation, although this would likely be secondary to its blockade of Golgi-derived traffic.
Inhibition of axonal growth during BFA treatment
The most dramatic effect of BFA treatment was the rapid inhibition of axonal growth. In polarized neurons, within 30 min of treatment, axonal elongation ceased, and shortly thereafter the axon started to retract. In unpolarized cells, BFA prevented the initiation of axonal outgrowth that marks the initial establishment of polarity. This time course of inhibition is consistent with the fastest rates of vesicle traffic observed from the ER to the cell surface (Wieland et al., 1987; Young et al., 1992; Andreose et al., 1996) , suggesting that axonal elongation is blocked concomitantly with the depletion of Golgi-derived vesicles. Studies that blocked organelle transport using optical tweezers further support this idea (Martenson et al., 1993) . The time course of inhibition of axonal growth correlated with the estimated time of fast axonal transport from the site of blockade to the growth cone. On the other hand, work showing that axonal membrane flow in chick DRG neurons is considerably greater than their elongation rate suggests a considerable pool of membrane is available for growth (Dai and Sheetz, 1995) .
What Golgi-derived materials are crucial for the maintenance and regulation of axonal growth and the development of polarity? One possibility is that the continuous availability of one or more membrane proteins is required to sustain axonal growth. The differences between the inhibitory effects of BFA and CHX argue Figure 7 . Axonal growth spurts persist for hours in brefeldin A. This set of phase contrast micrographs illustrates a cell just before BFA treatment ( A) and at several time points between 6 and 11 hr after the addition of BFA ( B-E). At 6 hr after BFA treatment, the axon had retracted markedly ( B). Twenty minutes later a growth spurt in excess of 10 m was evident ( C). Fifteen minutes later, axonal retraction was observed ( D). Several hours later, a motile axonal growth cone still persisted ( E). The individual frames shown were taken from a time-lapse video recording in which images were collected every 8 sec. Scale bar, 20 m. against this hypothesis. If both BFA and CHX act by depleting the availability of particular membrane proteins, then the difference in the time course of their effects should reflect the point at which these drugs block protein traffic along the exocytic pathway. The transit time from the ER to the cell surface for typical membrane proteins is in the range of 1-2 hr (L undstrom et al., 1993; Thorens et al., 1993; Akasaki et al., 1995; Pimental et al., 1996) . Only 1-2 min would be required for vesicles to travel to the growth cone by rapid transport. Yet, growth of CHX-treated axons was not affected until 3-4.5 hr after drug addition. Some multisubunit receptors do reside intracellularly for longer than 3 hr (Vitetta and Uhr, 1975; Devreotes et al., 1977) . However, in other types of neurons, inhibition of axonal growth by protein synthesis inhibitors requires an even longer time (Daniels, 1973; Estridge and Bunge, 1978; Lein and Higgins, 1991) . Furthermore, differences in the morphology of BFA-and CHX-treated neurons suggest their mechanisms of action may be different. The inhibition of axonal growth by CHX treatment coincided with loss of the growth cone and a thinning of the axon, whereas in BFAtreated axons the growth cone remained motile for hours after net elongation had stopped.
An alternative explanation of the effects of BFA treatment on axonal elongation is that the lipid components of the Golgiderived vesicles are required for axonal growth. L ogically, availability of bulk lipids should be required for growth, because the concomitant increases in surface area and volume of a growing axon would require the net addition of membranous material. Dai and Sheetz (1995) have proposed a model in which membrane tension could act to regulate neurite growth. In chick DRG neurons, they observed that the axonal membrane flowed toward the cell body, consistent with a relatively low membrane tension at the growth cone and a relatively high membrane tension at the cell body. In cases in which the membrane tension at the growth cone increases, such as with BFA treatment (Dai and Sheetz, 1995) , elongation of a neurite necessarily requires a stronger motile force. Increased membrane tension, caused by BFA blocking the insertion of new membrane, may be the mechanism by which axonal elongation ceases; if the tension at the growth cone reached a high enough level, then filopodial extension would tend to be inhibited, and retraction could be favored.
Perturbations in the levels of a single lipid species in the plasma membrane can also have significant effects on neurite outgrowth. For example, inhibitors of sphingolipid synthesis were shown to inhibit axonal or dendritic growth in a number of different neurons (Harel and Futerman, 1993; Furuya et al., 1995; Boldin and Futerman, 1997; Dechaves et al., 1997) . However, many of these effects require many hours or days in contrast to the rapid effects of BFA.
The development and maintenance of polarity
In hippocampal cultures, the transition a neuron undergoes from an apparently unpolarized cell with several identical neurites to a cell with a single axon that has acquired its defining morphological and molecular properties occurs quite abruptly, in as little as 1 hr (Dotti et al., 1988; Goslin and Banker, 1989; Deitch and Banker, 1993) . What induces this critical developmental transition? One possible explanation is that this phenotypic change is initiated by the induction of new gene expression or by the increased expression of certain key protein(s). The slow time course with which inhibitors of RNA or protein synthesis block the development of polarity argues against these possibilities. The percentage of cells with axons increased normally in the presence of CHX for at least 3 hr and in the presence of ACT D for at least 6 hr. This suggests that the full complement of proteins and mRNA required for the development of polarity can be present for several hours before polarity is actually established.
When axons of 1-d-old neurons are transected near the cell body, the polarity of the cell is often altered (Goslin and Banker, 1990) . A different neurite becomes the axon. When lesions are made at greater distances, the lesioned axon retains its identity. One hypothesis put forth to explain these effects is that the influx of Ca 2ϩ at the lesion site and its spread to the cell body determined which process eventually became the axon (Mattson et al., 1990 ). The present results show that polarity can be altered when Figure 8 . The effects of cycloheximide on neurite elongation. The set of phase contrast micrographs illustrates a cell just before treatment with 71 M cycloheximide ( A) and 2 hr (B), 3 hr (C), 6 hr (D), and 12 hr ( E) after treatment. Axonal growth continued normally for 3 hr after the addition of cycloheximide. By 6 hr, the axon had stopped growing and had retracted slightly, and its growth cone had disappeared. Over the next 6 hr, the axon became thinner and retracted still more. The minor processes also became thinner over time, but they did not retract. Scale bar, 20 m.
BFA treatment causes axons to retract. BFA treatment is unlikely to induce the influx of C a 2ϩ .
Conclusion
One key to understanding axonal growth and the development of polarity is the regulation of the trafficking of required materials. Much of the research concerning axonal growth has focused on the growth cone because it seems to be the primary site for the assembly and disassembly of the cytoskeleton involved in process outgrowth. The regulation of growth must also depend on the supply of membranous elements. The data presented here show that changes in the availability of Golgi-derived materials can also affect the outgrowth of axons. Further work examining vesicular trafficking during periods of selective growth of neurites should provide insight into how cells coordinate the supply of membrane material with the demands of growth. Within 1 hr of BFA treatment, the axon had begun to retract, and by 6 hr, it had retracted back to the length of the minor processes of the cell. After removal of BFA, the initial axon did not regrow. Instead one of the minor processes became the new axon. Scale bar, 20 m.
